 |
|
|
| |
ONYX-II: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Coadministered With
Ribavirin in Asian Adults With Genotype 1b Chronic Hepatitis C Virus Infection and Compensated Cirrhosis
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Lai Wei1, Guiqiang Wang2, Yan Luo3, Chi-Jen Chu4, Seung Woon Paik5, Jinlin Hou6, Jun Cheng7, Qing Xie8, Zhongping Duan9, Jia-Horng Kao10, Bo Fu3, Niloufar Mobashery3, Jeong Heo11
1Peking University Peoples Hospital, Beijing, China; 2Peking University First Hospital, Beijing, China; 3AbbVie Inc., North Chicago, Illinois, United States; 4Taipei Veterans General Hospital, Taipei City, Taiwan; 5Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea;
6Nanfang Hospital of Southern Medical University, Guangzhou, China; 7Beijing Di Tan Hospital, Capital Medical University, Beijing, China; 8Ruijin Hospital Shanghai Jiaotong, University School of Medicine, Shanghai, China; 9Beijing Youan Hospital Capital Medical University, Beijing, China;
10Nati onal Taiwan University Hospital, Zhongzheng District, Taiwan; 11Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
|
| |
|
|
|
|
|
